Sestamibi scintigraphy for parathyroid localisation: A reminder of the dangers of false positives

1Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

Abstract

Surgical parathyroidectomy is the only curative treatment for primary hyperparathyroidism. As minimally invasive parathyroidectomy increases in popularity, so does reliance on preoperative parathyroid localisation techniques. One such technique is sestamibi scintigraphy. We report a case of false-positive sestamibi scintigraphy caused by follicular variant of papillary thyroid carcinoma. Subsequent completion thyroidectomy was not possible due to widespread postoperative fibrosis. This case, therefore, highlights the potential dangers of false-positive results due to thyroid carcinoma and encourages surgeons to consider this possibility when faced with intrathyroidal or otherwise ambiguous parathyroid localisation results. Copyright 2014 BMJ Publishing Group. All rights reserved.

Cite

CITATION STYLE

APA

Whitcroft, K. L., & Sharma, A. (2014). Sestamibi scintigraphy for parathyroid localisation: A reminder of the dangers of false positives. BMJ Case Reports. https://doi.org/10.1136/bcr-2013-203225

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free